Skip to main content
Premium Trial:

Request an Annual Quote

Ingenuity Licenses Pathways Analysis Technology to Stanford Genome Center

NEW YORK, Nov. 3 (GenomeWeb News) - Ingenuity has licensed its Pathways Analysis technology to the Stanford Genome Technology Center, the company said today.


The Pathways Analysis system maps relationships between proteins, genes, complexes, cells, tissues, drugs, and diseases.


Ron Davis, the director of the Stanford Genome Center, first used the software in beta release, the company said. Davis' lab is collaborating with Ingenuity, of Mountain View, Calif., on developing new functionality to extend its capabilities.


Ingenuity has also recently licensed its  Pathways Knowledge database to GlaxoSmithKline, and has signed a software distribution deal with Affymetrix, an investor in the company.



The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.